Home Search

GWPH - search results

If you're not happy with the results, please do another search
marijuana stock news

gwph

GWPH Stock Chart & Overview Cara Therapeutics is a clinical-stage biotechnology company located in Stamford, CT focused on developing and commercializing new chemical entities designed...
marijuana stocks news

GW Pharmaceuticals plc (GWPH) to Report Second Quarter Financial Results and Host Conference Call...

GW Pharmaceuticals to Report Second Quarter Financial Results and Host Conference Call on 8 May, 2018 GW Pharmaceuticals plc (GWPH) (“GW” or “the Company”), a...
marijuana stocks news

GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol...

LONDON, April 12, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (GWPH) “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing...
marijuana stock news

GW Pharmaceuticals plc (GWPH) Announces Receipt of Notices of Allowance by the United States...

GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex® (cannabidiol) Patents GW Pharmaceuticals...
marijuana stocks news

GW Pharmaceuticals plc (GWPH) Receives Orphan Drug Designation from the European Medicines Agency

GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis GW Pharmaceuticals plc (GWPH) (“GW,”...
marijuana stock news

GW Pharmaceuticals plc (GWPH) Submits Marketing Authorisation Application in Europe for Epidiolex®

GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome GW Pharmaceuticals plc (GWPH) (“GW”...
marijuana stock news

GW Pharmaceuticals plc (GWPH) Announces Acceptance of NDA Filing for Epidiolex®

GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome GW Pharmaceuticals plc (GWPH) (“GW” or...
marijuana stock news

GW Pharmaceuticals plc (GWPH) Announces the Appointment of Three New Independent Members to its...

GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors GW Pharmaceuticals plc (GWPH) (“GW” or “the Company”), a biopharmaceutical...
marijuana stock news

GW Pharmaceuticals plc (GWPH) Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.

GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S. GW Pharmaceuticals plc (GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on...
marijuana stock news

GW Pharmaceuticals plc (GWPH) Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results

GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress GW Pharmaceuticals plc (GWPH) (GW, the Company or the Group),...

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com